PF-00835231

• Description:

  PF-00835231 is a CoV-2 cysteine 3C-like protease (3CLpro) inhibitor, with IC50s of 0.27 nM and 4 nM for SARS CoV-2 and SARS CoV-1 3CLpro, respectively.PF-00835231 is the active compound of the first anti-3CLpro regimen in clinical trials.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  944.06

• Molecular Formula:

  C48H63N8O12

• Notes:

  Research use only, not for human use.

• Receptor:

  Glucocerebrosidase

• CAS Number:

  870153-29-0